Ozempic CEO agrees to discuss lower prices for blockbuster weight loss drugs
Sort by
264 items
-
The Hill - Politics
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially” ...4 days ago -
MarketWatch - Business
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.4 days ago -
The New York Times - Health
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.4 days ago -
The New York Times - Business
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.4 days ago -
The New York Times - Business
What’s Next for Rate Cuts? The Fed Is Watching Jobs and Prices.
A Federal Reserve official predicted quarter point rate cuts if data looked ‘fine’. But he also set out a scenario for a pause — or faster reductions.4 days ago - Federal Reserve -
The New York Times - Business
What’s Next for Rate Cuts? The Fed Is Watching Jobs and Prices.
A Federal Reserve official predicted quarter point rate cuts if data looked ‘fine’. But he also set out a scenario for a pause — or faster reductions.4 days ago - Federal Reserve -
The Hill - Politics
South Carolina prepares for first execution in 13 years after securing drugs
South Carolina inmate Freddie Eugene Owens is set to undergo the state’s first execution in 13 years, about a year after the state obtained the necessary drugs to carry out a lethal injection. ...4 days ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high4 days ago -
Inc. - Business
Amazon and Starbucks CEOs Present Contrast in RTO Mandates
While Amazon's Andy Jassy got criticized for his order to resume a five-day week in the office, incoming Starbucks CEO Brian Niccol encouraged full-week presence--but will let employees decide for ...4 days ago - Amazon -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.4 days ago -
NBC News - Top stories
She dreamed of a second child but now says a little white pill cost her a son
Jennifer Nosek alleges in a complaint that midwife Heather Baker gave her a "homeopathic" that was actually the drug misoprostol shortly before her son's death.4 days ago -
CBS News - Top stories
Kamala Harris discusses her gun ownership on livestream with Oprah
Thursday night in her livestream with Oprah, Kamala Harris discussed her gun ownership, saying, "If somebody breaks in my house they're getting shot." CBS News campaign reporter Shawna Mizelle has ...4 days ago - Kamala Harris -
-
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.4 days ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.4 days ago -
The Hill - Politics
Harris and Oprah hold star-studded event to discuss hot-button issues
Vice President Harris and media mogul Oprah Winfrey sat down for an event in Michigan to discuss issues ranging from immigration to the economy, reproductive rights and gun violence prevention. The ...4 days ago -
The Wall Street Journal - Business
Nike CEO John Donahoe Stepping Down After Rocky Tenure
Nike said John Donahoe will retire as chief executive and from the board, and named his successor, Elliott Hill, who retired from the sneaker maker in 2020.5 days ago -
The Wall Street Journal - Business
Nike CEO John Donahoe Stepping Down After Rocky Tenure
Nike said John Donahoe will retire as chief executive and from the board, and named his successor, Elliott Hill, who retired from the sneaker maker in 2020.5 days ago -
The Wall Street Journal - Business
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue
FedEx’s results were dragged down by weaker-than-expected demand, particularly in the U.S. domestic package market.5 days ago -
The Wall Street Journal - Business
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue
FedEx’s results were dragged down by weaker-than-expected demand, particularly in the U.S. domestic package market.5 days ago -
The New York Times - Health
Research Leading to Ozempic Honored by 2024 Lasker Awards
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to stop H.I.V. and for immune system discoveries.5 days ago -
The Wall Street Journal - Business
TD Bank Taps Veteran to Succeed Bharat Masrani as CEO
Masrani plans to retire in 2025 after 38 years with the Canadian lender and more than a decade as CEO.5 days ago -
The Wall Street Journal - Business
TD Bank Taps Veteran to Succeed Bharat Masrani as CEO
Masrani plans to retire in 2025 after 38 years with the Canadian lender and more than a decade as CEO.5 days ago -
The Wall Street Journal - Tech
Intel CEO Moves to Further Cut Costs and Separate Chip Making and Design
Company will make manufacturing operations an independent subsidiary and pause construction on plants in Europe and Asia.September 16